BioCentury
ARTICLE | Financial News

Mirati raises $101.3M in follow-on

September 17, 2015 1:38 AM UTC

Mirati Therapeutics Inc. (NASDAQ:MRTX) raised $101.3 million through the sale of 2.3 million shares at $45 in a bumped-up follow-on underwritten by Citigroup; Barclays; and Leerink. The company proposed after market close Monday to raise $80 million when its stock was at $46.29. Mirati lost $3.36 to $44.34 on Wednesday. ...